Trending Stocks
Top 10 from Yahoo Finance + StockTwits with daily-bar technical analysis. Cached 5 min. Educational only — not financial advice.
$7.06
+15.00%
Wendy's Company (The)
Top Midday Stories: GE Vernova to Acquire Trench Group for $9 Billion; Wendy's Receives $1.4 Billion Takeover Offer From Trian-Led GroupMT NewswiresWendy’s activist investors propose $1.4B buyoutRestaurant DiveWendy’s Shares Rise 15% Following $1.4 Billion Takeover Proposal From Trian Fund ManagementInvestorsHub
WATCH SELL
Approaching resistance $7.20, RSI 59
BUY ZONE
$5.94 – $6.26
SELL ZONE
$6.88 – $7.20
RSI59
TRENDBEARISH
EMA20$6.51
EMA50$7.05
ATR$0.32
$162.94
+12.10%
SK hynix Inc.
Neocloud Stocks Like CoreWeave Rebound Despite Elon Musk Predicting 'Guppy-Level Death'Investor's Business DailyStock market today: Nasdaq wavers, S&P 500 and Dow climb ahead of Fed decision, Big Tech earningsYahoo FinanceCramer: Micron “Should Be the Biggest Winner” as SK Hynix Predicts Memory Shortage Through 2030TIKR
HOLD
Bearish trend, RSI 53 not yet washed out
BUY ZONE
$130.79 – $139.62
SELL ZONE
$187.14 – $195.97
RSI53
TRENDBEARISH
EMA20$155.19
EMA50$159.26
ATR$8.83
$235.41
+12.87%
Vertiv Holdings, LLC
Neocloud Stocks Like CoreWeave Rebound Despite Elon Musk Predicting 'Guppy-Level Death'Investor's Business DailyRack Mount UPS - Global Strategic Business Report: Capitalize on the US$2.7B-to-US$4.4B Surge by 2032 as ABB, APC by Schneider Electric, Eaton, and Vertiv Battle for Edge DominanceGlobeNewswireWhy Is Vertiv Holdings Co (VRT) Expanding Into Grid And Liquid Cooling?Simply Wall St.
HOLD
Bearish trend, RSI 54 not yet washed out
BUY ZONE
$187.24 – $200.37
SELL ZONE
$244.97 – $258.10
RSI54
TRENDBEARISH
EMA20$221.99
EMA50$239.39
ATR$13.13
$10.04
-17.54%
SELLAS Life Sciences Group, Inc
Sellas Sinks 18% as Phase 3 Leukemia Trial Reaches “Critical Milestone” Ahead of Final DataTIKRSELLAS Life Sciences Reaches 80th Event in Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid LeukemiaGlobeNewswireSLS Stock Gets A BlackRock Spotlight Ahead Of Phase 3 AML Data — Bulls Spot 2027 European GPS Approval ForecastStocktwits
BUY
Near support $9.70, RSI 41 (oversold)
BUY ZONE
$9.70 – $10.76
SELL ZONE
$11.64 – $12.70
RSI41
TRENDBEARISH
EMA20$11.47
EMA50$11.89
ATR$1.06
$25.02
-15.93%
Enphase Energy, Inc.
Enphase Energy Facing Soft US Demand, Challenges in Other Markets, Morgan Stanley SaysMT NewswiresEnphase Q3 Earnings: 3 Key Takeaways for Long-Term InvestorsMotley FoolEnphase Eyes AI Data Centers as Home Solar Demand FadesGuruFocus.com
BUY
Near support $23.83, RSI 25 (oversold)
BUY ZONE
$23.83 – $25.85
SELL ZONE
$32.17 – $34.19
RSI25
TRENDBEARISH
EMA20$31.20
EMA50$33.97
ATR$2.02
$91.01
-3.75%
Robinhood Markets, Inc.
200,000 Robinhood Customers Now Let AI Trade for Them24/7 Wall St.Robinhood Stock Tumbles as Crypto Revenue Crashes 55%GuruFocus.comStock Market Today: Dow Gains Meekly As Alphabet Rises Ahead Of Earnings (Live Coverage)Investor's Business Daily
BUY
Near support $89.15, RSI 34 (oversold)
BUY ZONE
$89.15 – $94.41
SELL ZONE
$114.12 – $119.38
RSI34
TRENDBEARISH
EMA20$101.54
EMA50$103.19
ATR$5.26
$65.45
-0.50%
Uber Technologies, Inc.
Instacart Sinks 6% as Uber Reportedly Walks Away From Talks to Buy the “Prized Asset”TIKRAmex Platinum's $600 hotel credit now comes with a catch starting in 2027Yahoo Personal FinanceWhat Drives the Long-Term Bull Case for Uber Technologies (UBER)?Insider Monkey
BUY
Near support $64.69, RSI 36 (oversold)
BUY ZONE
$64.69 – $66.45
SELL ZONE
$70.32 – $72.08
RSI36
TRENDBEARISH
EMA20$68.60
EMA50$71.02
ATR$1.76
$42.10
-6.57%
Boston Scientific Corporation
Boston Scientific Lowers Full-Year Outlook Amid Cyberattack ImpactMT NewswiresBSX Stock Crashes To 4-Year Lows: Boston Scientific Sees Q4 Sales Declining, CEO Remains Confident In ‘Long-Term Strategy’StocktwitsBoston Scientific Warned You. It Slashed Earnings Guidance After Cyberattack Hits Business.Barrons.com
NEUTRAL
Bearish trend, RSI 39, mid-range
BUY ZONE
$39.57 – $41.07
SELL ZONE
$44.66 – $46.16
RSI39
TRENDBEARISH
EMA20$44.29
EMA50$45.55
ATR$1.50
$57.16
+27.95%
Genmab A/S
Genmab Says Phase 3 Trial of Petosemtamab Combination Meets Both Primary Endpoints; Shares RiseMT NewswiresGenmab stock surges 16% on positive cancer trial resultsInvesting.comGenmab Announces Statistically Significant, Clinically Meaningful Improvement in Overall Survival and Objective Response with Petosemtamab Combination at First Interim Analysis in First-Line R/M Patients with PD-L1+ Head and Neck CancerBusiness Wire
SELL
Near resistance $58.54, RSI 90 (overbought)
BUY ZONE
$33.72 – $36.06
SELL ZONE
$56.20 – $58.54
RSI90
TRENDBULLISH
EMA20$40.79
EMA50$36.79
ATR$2.34
$882.69
-1.38%
GE Vernova Inc.
GE Vernova Stock Falls; 'New Orders And New Slots Missed By A Mile'Investor's Business DailyTop Midday Stories: GE Vernova to Acquire Trench Group for $9 Billion; Wendy's Receives $1.4 Billion Takeover Offer From Trian-Led GroupMT NewswiresGE Vernova Stocks Decline 3.82% With Trench Deal Adding a Financing HurdleGuruFocus.com
NEUTRAL
Bearish trend, RSI 44, mid-range
BUY ZONE
$796.41 – $845.98
SELL ZONE
$1,003.21 – $1,052.78
RSI44
TRENDBEARISH
EMA20$914.71
EMA50$941.45
ATR$49.57